Moreover, AURKA overexpression in TNBC identifies as a factor of early recurrence and poor prognosis [42] and AURKA showed 3′UTR shortening in poor-prognosis patients of both breast and lung cancer [43]. This evidence concerns the gene AURKA and lung cancer.